International journal of colorectal disease
-
Int J Colorectal Dis · Mar 2016
Multicenter Study Observational StudyFerric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.
The purpose of the study was to evaluate the efficacy of preoperative intravenous (IV) ferric carboxymaltose (FCM) administration vs. no-IV iron in colon cancer (CC) anemic patients undergoing elective surgery with curative intention. ⋯ Preoperative ferric carboxymaltose treatment in patients with CC and iron deficiency anemia significantly reduced RBC transfusion requirements and hospital length of stay, reaching higher response rates and percentages of normalized hemoglobin levels both at hospital admission and 30 days post-surgery.
-
Int J Colorectal Dis · Mar 2016
Current use of diverting stoma in anterior resection for cancer: population-based cohort study of total and partial mesorectal excision.
A diverting stoma is commonly used to reduce the risk of anastomotic leakage when performing total mesorectal excision (TME) in anterior resection for rectal cancer. The purpose of this study was to evaluate the impact of fecal diversion in relation to partial mesorectal excision (PME). ⋯ The benefit of a diverting stoma concerning anastomotic leakage in this patient group seems doubtful. Moreover, the diverting stoma itself may contribute to the high rate of permanent stomas.